Through the RT-PCR technique, Sun et al reported that LINC02381 enhanced CBX5 expression by binding the CBX5 promoter and activating CBX5 transcription in glioma (Sun et al., 2021). This evidence concerns the gene CBX5 and central nervous system cancer.